
    var toolTipArray;

    var tooltipLibrary = [{"Key":"Adenocarcinoma","Value":"A cancerous tumor that arises in or resembles glandular tissue."},{"Key":"Adjunct agent","Value":"In cancer therapy, a drug or substance used in addition to the primary therapy."},{"Key":"Adjuvant chemotherapy","Value":"A term used to describe the role of chemotherapy relative to other cancer treatments. It is typically given alone or with radiation after surgical resection."},{"Key":"Adjuvant radiation therapy","Value":"The use of radiation after treatment in order to prevent a cancer from recurring."},{"Key":"Anaplastic","Value":"A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells."},{"Key":"Anastomosis","Value":"The joining together of two ends of healthy bowel after diseased bowel has been cut out (resected) by the surgeon. This may be contrasted to a colostomy, when the bowel ends may be permanently diverted, or anastamosed at a later surgery."},{"Key":"Antigen","Value":"A substance that is recognized by the body as being foreign and, as such, can trigger an immune response."},{"Key":"Archived Tumor Sample","Value":"A tumor sample that has been routinely preserved and stored. Tumor tissue is commonly preserved for storage by being treated with a preservative called formalin and then embedded in paraffin (wax)."},{"Key":"Aromatase Inhibitor","Value":"A medication that reduces the amount of estrogen in the body. Aromatase inhibitors may be used to treat women with estrogen-receptor-positive breast cancer."},{"Key":"Barium enema","Value":"A barium enema is a series of x-rays of the lower gastrointestinal tract. The barium enema procedure consists of the insertion of barium (a radiolucent solution) to coat the lower gastrointestinal tract. The barium coats the lower gastrointestinal tract and x-rays are taken. On X-ray, areas in which the barium \"lights up\" may indicate abnormal cell proliferation. This procedure is also called a lower GI series."},{"Key":"Biopsy","Value":"A procedure where tumor tissue is removed from the body for laboratory examination to determine whether or not cancer is present. A biopsy can be performed using a needle to extract a small piece of tissue or as a surgical procedure to remove a larger piece of tissue."},{"Key":"BRCA1 and BRCA2","Value":"Genes that normally help control cell growth. A person who inherits an altered version of the BRCA1 and/or BRCA2 gene(s) has a higher risk of developing breast and ovarian cancer."},{"Key":"Cancer","Value":"A condition in which abnormal cells divide without control or fail to die as part of a normal cell's lifecycle. Cancer cells can also invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body."},{"Key":"Cancer staging","Value":"The process of assigning a descriptor (usually numbers I to IV) of how much a cancer has spread in the body. Criteria for staging include: size of tumor, amount of tissue penetration, whether it has invaded adjacent organs, how many lymph "},{"Key":"Carcinoma","Value":"Any malignant cancer that comes from epithelial cells. Carcinomas will invade surrounding tissue, and have the propensity to metastasize to the lymph nodes and beyond."},{"Key":"Carcinoma in situ","Value":"Epithelial tumor cells confined to the tissue of origin, without invasion through the basement membrane."},{"Key":"Chemotherapy","Value":"Treatment with cytotoxic drugs that destroy cancer cells (fast-growing cells). Chemotherapy may be used in addition to surgery, and is sometimes used in combination with other therapies such as radiation therapy or hormonal therapy."},{"Key":"Chromosome","Value":"A microscopically visible carrier of genetic information."},{"Key":"Clinical Laboratory Services","Value":"The biological, microbiological, serological, chemical, immuno-hematological, hematological, biophysical, cytological, pathological or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention or treatment of any disease or impairment of - or the assessment of the health of - human beings."},{"Key":"Clinical Trial","Value":"A research study to test drugs, procedures or testing technologies to determine whether these are effective and/or safe."},{"Key":"Clinically Validated","Value":"Determination that a test is accurate in determining the presence of, or predicting the risk for, a health condition or phenotype, including determination of sensitivity, specificity and positive and negative predictive values."},{"Key":"Colectomy","Value":"Surgical resection of all or part of the colon (also called the large intestine)."},{"Key":"Colitis","Value":"inflammation of the colon. Colitis has many forms including ulcerative, Crohn's, infectious, pseudomembranous, and spastic."},{"Key":"Colon polyp","Value":"A fleshy growth on the inside (the lining) of the colon."},{"Key":"Colonoscopy","Value":"Inspection through a fiber-optic scope of the inside of the colon."},{"Key":"Colorectal","Value":"Related to the colon and/or rectum."},{"Key":"Core Biopsy","Value":"A procedure which uses a needle to remove a small, intact sample of tissue from an identified breast mass in order to examine it and obtain a preliminary diagnosis."},{"Key":"Diagnosis","Value":"Identification of a condition, such as breast cancer, by its signs and symptoms and the results of laboratory tests or other examinations."},{"Key":"Distant Recurrence","Value":"The spread of cancer to parts of the body other than the place where the cancer first occurred. In breast cancer, the cancer can spread to the lungs, liver, brain or bones."},{"Key":"Dukes staging system","Value":"A system of staging rectal cancers developed by Cuthbert Duke in 1932. The original system had 3 stages but has been modified over time to include four stages with variations on two of the four stages."},{"Key":"Dysplasia","Value":"A term that refers to abnormal cells that have the potential to progress to cancer."},{"Key":"Early-Stage Invasive Breast Cancer","Value":"A term that can be used to describe stage I and II, and some stage III breast cancer."},{"Key":"Endoscope","Value":"A long slender medical instrument for examining the interior of a bodily organ or performing minor surgery."},{"Key":"Endoscopy","Value":"Visual examination of a bodily orifice, canal or organ using an endoscope."},{"Key":"ER (Estrogen Receptor)","Value":"A feature (protein) that may be present on certain cells to which estrogen molecules can attach. The term \"ER positive\" refers to tumor cells that contain the estrogen-receptor protein. These cells are generally sensitive to hormone therapy."},{"Key":"Gastroenterologist","Value":"a physician who specializes in diseases of the gastrointestinal tract."},{"Key":"Gastroenterology","Value":"The branch of medicine that focuses on the digestive system and its disorders."},{"Key":"Gene","Value":"The functional and physical units of inheritance that are passed from parents to their offspring. The genes found in normal breast tissue can change their \"expression\", which can give rise to breast cancer."},{"Key":"Gene Expression","Value":"The level of activity of a gene or group of genes."},{"Key":"Gene Expression Profile","Value":"A picture of the activity or expression of multiple genes from a single specimen."},{"Key":"Genetics","Value":"The study of genes and heredity. Heredity is the passing of genetic information and traits, such as eye color or an increased chance of getting a certain disease, from parents to offspring."},{"Key":"Genome","Value":"The complete genetic material of a living thing."},{"Key":"Genomic Test","Value":"A test that looks at groups of genes and how active they are. This activity can influence how a cancer is likely to grow and respond to treatment."},{"Key":"Genomics","Value":"The study of complex sets of genes, how they are expressed in cells (what their level of activity is), and the role they play in biology."},{"Key":"Hand Foot Syndrome (Palmar-Plantar Erythrodysesthesia)","Value":"Also called hand-foot syndrome or hand-to-foot syndrome, Palmar-Plantar Erythrodysesthesia is a side effect, which can occur with several types of chemotherapy or biologic therapy drugs used to treat cancer. Leakage of the drug through the capillaries of the skin of the hands and feet can cause redness, tenderness, and peeling of the skin of the palms and soles."},{"Key":"Hereditary Nonpolyposis Colon Cancer (HNPCC)","Value":"An inherited cancer syndrome. Individuals with HNPCC have an increased risk of developing colon and rectal cancer, as well as other types of cancer."},{"Key":"Hormonal Treatment (Hormone Therapy)","Value":"Medications used to reduce the effect of hormones in the body. In many cases of breast cancer, hormones can fuel the growth of breast cancer. Common hormonal therapies include tamoxifen and a newer class of drugs called aromatase inhibitors. Hormonal therapies are used to treat women with estrogen-receptor-positive breast cancer."},{"Key":"Hormone Receptor","Value":"A protein on the surface of a tumor cell that binds to a certain hormone, activating tumor growth."},{"Key":"Human Genome Project","Value":"An international research and technology-development effort aimed at mapping and sequencing the entire genome of human beings."},{"Key":"In Situ","Value":"Non-invasive cancer in which abnormal cells are isolated within the lobes or milk ducts of the breast and have not spread to nearby tissue."},{"Key":"Invasive Breast Cancer","Value":"Cancer that has spread from where it started in the breast into surrounding, healthy tissue. Most invasive breast cancers start in the ducts (tubes that carry milk from the lobules to the nipple). Invasive breast cancer can spread to other parts of the body through the blood and lymph systems. Invasive breast cancer is also called infiltrating breast cancer."},{"Key":"Local Recurrence","Value":"The reappearance of cancer in the part of the body where it first occurred."},{"Key":"Lumpectomy","Value":"A surgical procedure that removes a localized mass of tissue, including the breast cancer tumor and a small amount of normal, non-cancerous tissue surrounding the tumor."},{"Key":"Malignant","Value":"Tending to be severe and become progressively worse; a malignant tumor is one that has the ability to invade and destroy nearby tissue and/or spread (metastasize) to other parts of the body."},{"Key":"Mastectomy","Value":"A surgical procedure to remove all or a large part of the breast."},{"Key":"Metastasize","Value":"A term that is used to refer to cancer spreading from its site of origin to other sites in the body."},{"Key":"Metastatic Breast Cancer","Value":"Advanced breast cancer that has spread beyond the breast and local lymph nodes to other parts of the body such as the lungs, liver, brain or bones or other tissues."},{"Key":"Molecular Diagnostics","Value":"The measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes. "},{"Key":"Newly Diagnosed","Value":"A term used to describe breast cancer that has recently been identified."},{"Key":"Node-Negative Breast Cancer","Value":"Breast cancer that has not spread to the lymph nodes."},{"Key":"Node-Positive Breast Cancer","Value":"Breast cancer that has spread to the lymph nodes (most commonly the axillary lymph nodes under the arms)."},{"Key":"Oncotype DX Test","Value":"The Oncotype DX breast, colon, and prostate cancer assays are unique diagnostic tests that help patients and their physicians make informed, individualized treatment decisions. To learn more about the Oncotype DX tests for DCIS, breast, colon and prostate cancer please visit the http://www.oncotypedx.com/ Oncotype DX product website or call Tel: +1 (888) ONCOTYPE"},{"Key":"Oncologist","Value":"A physician who specializes in the study and treatment of tumors."},{"Key":"Oncology","Value":"The study and treatment of cancer."},{"Key":"Pathologist","Value":"Physician who identifies diseases by studying cells and tissues under a microscope."},{"Key":"Pathology Report","Value":"A report ordered by authorized healthcare professionals that describes what was found in tissue removed from the patient's body. The report is generated after the tumor and surrounding tissue are checked by a pathologist. It usually includes information on the tumor's grade and stage."},{"Key":"Polyethylene glycol","Value":"An electrolyte-based laxative solution used to clean the bowel before a gastrointestinal exam."},{"Key":"Polyp","Value":"A usually nonmalignant growth or tumor protruding from the mucous lining of an organ, such as the colon. Colon polyps are fleshy growths that occur on the inside (the lining) of the large intestine."},{"Key":"PR (Progesterone Receptor)","Value":"A feature (protein) that may be present on certain cells to which progesterone molecules can attach. The term \"PR positive\" refers to tumor cells that contain the progesterone receptor protein. These cells are generally sensitive to hormone therapy."},{"Key":"Predispose","Value":"To make more likely or render susceptible."},{"Key":"PSA (Prostate-specific antigen)","Value":"A protein exclusively produced by the prostate. Increased levels of PSA may be found in the blood of men who have prostate cancer or other prostate diseases such as BPH (benign prostatic hyperplasia) or inflammation of the prostate."},{"Key":"Radiation Therapy","Value":"The use of radiation to destroy cancer cells. Radiation therapy may be used before or after surgery, and is sometimes used in combination with chemotherapy. Radiation is used for local control of the cancer at the site of the tumor."},{"Key":"Recurrence","Value":"The return of cancer after treatment. This can be either local (at the site of the original tumor), or distant (beyond the original site)."},{"Key":"Resection","Value":"Surgery to remove a cancer and some surrounding tissue."},{"Key":"Sarcoma","Value":"A malignant tumor growing from connective tissues, such as cartilage, fat, muscle, or bone."},{"Key":"Screening (for breast cancer)","Value":"Looking for masses or suspicious areas in breast tissue on a periodic basis, usually with mammography."},{"Key":"Screening (for colon cancer)","Value":"Looking for masses or suspicious areas in colon tissue on a periodic basis."},{"Key":"Sigmoidoscopy","Value":"Inspection through a fiber-optic scope of the inside of the sigmoid colon, which is part of the large intestine that empties into the rectum. The test is useful for diagnosing the cause of diarrhea, constipation, or abdominal pain, and for identifying cancerous tissue."},{"Key":"Stage I Breast Cancer","Value":"The tumor is up to 2 centimeters in diameter and has not spread beyond the breast."},{"Key":"Stage IIA Breast Cancer","Value":"The tumor is up to 2 centimeters and has spread to the axillary lymph nodes under the arm, or the tumor is between 2 and 5 centimeters and has not spread to the lymph nodes."},{"Key":"Stage IIB Breast Cancer","Value":"The tumor is between 2 and 5 centimeters and has spread to the lymph nodes under the arm, or the tumor is larger than 5 centimeters in diameter and has not spread to the lymph nodes."},{"Key":"Stage IIIA Breast Cancer","Value":"The tumor is larger than 5 centimeters in diameter and has spread to the lymph nodes under the arm, or the tumor is any size and has spread more extensively in the lymph nodes."},{"Key":"Stage IIIB Breast Cancer","Value":"The tumor is any size and has extended to other tissues near the breast; the tumor may or may not have spread to the lymph nodes."},{"Key":"Stage IV Breast Cancer","Value":"Cancer that has spread (metastasized) to other locations in the body, such as the lungs, liver, bones or brain."},{"Key":"Staging","Value":"A classification system for breast cancer based on the size of the tumor, whether the cancer has spread to the lymph nodes, and whether the cancer has spread to other sites in the body (metastasis)."},{"Key":"Surveillance/Follow-Up","Value":"An ongoing assessment by a patient's medical team, once treatment has been completed, to assess the cancer's remission and to look for any evidence of a cancer's return."},{"Key":"Synchronous cancer","Value":"Multiple primary cancers occurring simultaneously."},{"Key":"Syndrome","Value":"A set of signs and symptoms that tend to occur together and which reflect the presence of a particular disease or an increased chance of developing a particular disease."},{"Key":"TAILORx","Value":"Although the Oncotype DX test has already been approved for use, research involving the test is ongoing. The Oncotype DX test plays a key role in a current clinical trial, the Trial Assigning Individualized Options for Treatment (Rx), known as TAILORx. Participants will be divided into different treatment groups depending on their Recurrence Score results. Patients with Recurrence Score results of less than 11, who are at low risk for recurrence and for whom chemotherapy is expected to provide little benefit, will receive hormone therapy alone. Patients with Recurrence Score results greater than 25, who are at higher risk for recurrence and for whom chemotherapy is expected to provide substantial benefit, will receive hormonal therapy and chemotherapy. Patients with Recurrence Score results between 11 and 25, whose risk for recurrence is moderate and for whom the benefit of chemotherapy is unclear, will be randomized to treatment with hormonal therapy plus chemotherapy versus hormonal therapy alone. The primary objective of the trial is to determine whether hormonal therapy alone offers no less benefit than chemotherapy plus hormonal therapy in women whose Recurrence Score results range from 11 to 25. For more information, please visit the http://www.ecog.org/general/tailorx.html website."},{"Key":"Tamoxifen","Value":"A medication that interferes with the activity of the hormone estrogen to prevent it from fueling the growth of breast cancer. Tamoxifen is used to treat women with estrogen-receptor-positive breast cancer."},{"Key":"TNM Classification of Malignant Tumors (TNM)","Value":"A cancer staging system that describes the extent of cancer in a patient's body. TNM literally describes Tumor/Nodes/Metastasis. T describes the size of the tumor and whether it has invaded nearby tissue, N describes the number of regional lymph nodes that are involved, and M describes the presence of other metastases. This system is jointly maintained by the International Union Against Cancer (UICC), and the American Joint Committee on Cancer."},{"Key":"Treatment Monitoring","Value":"An ongoing and frequent assessment by the medical team, during the time of treatment, to monitor how the patient is tolerating the treatment and how the cancer is responding."},{"Key":"Tumor","Value":"Tissue growth where the cells that make up the tissue have multiplied uncontrollably. A tumor can be benign (non-cancerous) or malignant (cancerous)."},{"Key":"Tumor Grade","Value":"The characterization of a tumor based on how similar in appearance the cancer cells are to normal cells, and on how many of those tumor cells are dividing. Tumor grade is one of many factors that, when used in combination, can indicate how aggressive a patient's cancer is."},{"Key":"Tumor Stage","Value":"This is a number that refers to the size of the tumor and whether the cancer has spread. Tumor stage, expressed as the tumor T score, is one of many factors that, when used in combination, can indicate how aggressive a patient's cancer is."},{"Key":"Ulcerative colitis","Value":"A disease where sores, or ulcers, form in the top layers of the lining of the large intestine. Inflammation usually occurs in the lower part of the colon and rectum."},{"Key":"Wire Localization Biopsy","Value":"A type of biopsy performed when an abnormality can be seen on a mammogram but cannot be felt.  A wire localization biopsy utilizes a mammogram to locate and identify the breast abnormality, after which a biopsy is performed."}]
        $(document).ready(function () {

            toolTipArray = $("tooltip");
            for (index = 0; index < toolTipArray.length; ++index) {
                for (tooltips = 0; tooltips < tooltipLibrary.length; ++tooltips) {

                    if (toolTipArray[index].childNodes[0].data.toLowerCase() == tooltipLibrary[tooltips]['Key'].toLowerCase()) {
                        toolTipArray[index].setAttribute('data-toggle', 'tooltip');
                        toolTipArray[index].setAttribute('title', tooltipLibrary[tooltips]['Value']);
                        toolTipArray[index].style.fontWeight = "900";
                        toolTipArray[index].style.cursor = "pointer";
                    }
                }
            }
            $('a[href^="login"]').not('a[href*=gusdecool]').attr('target', '_blank');

        });

    $(document).ready(function () {
        $('[data-toggle="tooltip"]').tooltip();
    });

I Agree
Genomic Health does not give treatment for cancer or advise patients on their treatment plans. Anyone in doubt about their own health or cancer should seek medical advice from a qualified healthcare professional.
PlaceHolder
Toggle navigation
MENU
WHO WE ARE
WHAT WE DO
ONCOTYPE IQ PRODUCTS
WHO WE HELP
JOIN OUR TEAM
Investors
Newsroom
Resources
Portal Login
WHO WE ARE
BACK
Overview
Our Mission
Company Timeline & Milestones
Leadership
Our Founders
Contact Us
WHAT WE DO
BACK
Overview
Clinical Leadership
World Class Commercial Channel
Patient Advocacy
ONCOTYPE IQ PRODUCTS
BACK
Overview
Oncotype DX
Oncotype DX for Breast Cancer
Oncotype DX for Prostate Cancer
Oncotype DX for Colon Cancer
Our Product Pipeline
WHO WE HELP
BACK
Overview
JOIN OUR TEAM
BACK
Overview
U.S. Benefits
International Benefits
United States - English
BACK
United States - English
Deutschland - Deutsch
France - Français
Italia - Italiano
Japan - Japanese
United Kingdom - English
Investors
Newsroom
Resources
Portal Login
United States - English
Deutschland - Deutsch
France - Français
Italia - Italiano
Japan - Japanese
United Kingdom - English
Toggle navigation
WHO WE ARE
WHAT WE DO
ONCOTYPE IQ PRODUCTS
WHO WE HELP
JOIN OUR TEAM
Genomic Health is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today.
LEARN MORE
Overview
Our Mission
Company Timeline & Milestones
Leadership
Our Founders
Contact Us
Genomic Health and Oncotype IQ – Delivering Precision Medicine
Watch how Genomic Health continues to transform cancer care around the world.
WATCH VIDEO
It is our mission to transform treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services for patients.
LEARN MORE
Overview
Clinical Leadership
World Class Commercial Channel
Patient Advocacy
Individual Molecular Fingerprint of Tumors
Kim Popovits discusses devising personalized medicine in the treatment of breast cancer and colon cancer.
WATCH VIDEO
Our portfolio of tests is aimed at delivering genomic intelligence that optimizes treatment decisions throughout the cancer patient journey.
LEARN MORE
Overview
Oncotype DX
Oncotype DX for Breast Cancer
Oncotype DX for Prostate Cancer
Oncotype DX for Colon Cancer
Our Product Pipeline
Not All Breast Cancer is the Same. 
Get Your Oncotype DX Score.
Hear how breast cancer survivors personalized their cancer treatment with Oncotype DX.
WATCH VIDEO
Genomic Health is driven by the commitment to improving the lives of cancer patients.
LEARN MORE
Overview
Your Prostate Your Decision: Interview with Dan
Dan was diagnosed with early-stage prostate cancer. Watch Dan talk about his experience with the Oncotype DX prostate cancer test.  
WATCH VIDEO
Inspired by the Life, changing work that we do? Be a part of the world's leading provider of genomic cancer diagnostic tests.
LEARN MORE
Overview
U.S. Benefits
International Benefits
The Genomic Health Brand and Company Mission
Watch CEO Kim Popovits and others discuss the motivation, inspiration, and rewards of working at Genomic Health, as well as the company’s vision for the future.
WATCH VIDEO
Toggle Search
✖
Life, changing.
More than 900,000 cancer patients worldwide have used our Oncotype DX tests to personalize treatments and improve outcomes.
Our Mission
Genomic Health’s mission is to transform treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services.
READ MORE
Oncotype IQ
Our portfolio of tests and services is aimed at delivering genomic intelligence that optimizes treatment decisions and outcomes throughout the cancer patient journey.
READ MORE
A "Top 5" Breast Cancer Innovation
In the latest of over 1,000 articles worldwide this year reporting on Oncotype DX and TAILORx, Parade has chosen the TAILORx trial as one of the top 5 innovations in breast cancer research for 2018. 
READ NOW
Making An Impact
Genomic Health is leading in the precision medicine revolution to eliminate the "one-size-fits-all" approach to cancer treatment.
Our Pipeline
Developing liquid- and tissue-based genomic tests that address critical treatment questions throughout all stages of cancer.
LEARN MORE
TAILORx: Transforming the Treatment of Breast Cancer
Landmark TAILORx results demonstrate that the Oncotype DX Breast Recurrence Score Test definitively identifies the 70% of women with early-stage breast cancer who receive no benefit from chemotherapy, and the 30% of women for whom chemotherapy benefit can be life-saving.
WATCH VIDEO
World Class Commercial Channel 
We deliver over 400 Oncotype DX test results per day to more than 90 countries through our centralized clinical laboratory, serving physicians and patients with our industry-leading customer service team and more than 200 sales and managed care representatives around the world.
LEARN MORE
Broadening Reimbursement for Patients Worldwide
Genomic Health is dedicated to securing reimbursement to ensure cancer patients around the world have access to our clinically actionable Oncotype DX tests. Outside the U.S., there are over 260 million lives covered and growing. The Oncotype DX prostate cancer test is now covered by Medicare in the U.S. for qualified patients, giving nearly 60,000 prostate cancer patients the opportunity to personalize their cancer treatment. 
LEARN MORE
Unsurpassed Scientific and Clinical Expertise
Our expertise consistently demonstrates to physicians, patients and payors that our tests are improving treatment decisions and outcomes, providing significant benefit from both a care and cost perspective.

LEARN MORE
“Genomic testing helped me make my decision. I would advise anybody to get all the information you can before you make a decision about your life and your body.”
Jim G.
READ MORE
Our People
Genomic Health Employees on the Gratification of Their Jobs 
Genomic Health Employees on the Company's Higher Purpose 
Previous
Next
Who We Are
Our Mission
Timeline & Milestones
Leadership
Contact Us
Who We Help
What We Do
Clinical Leadership
Commercial Channel
Patient Advocacy
Join Our Team
Careers
U.S. Benefits
International Benefits
Oncotype IQ Products
Oncotype DX
For Breast Cancer
For Prostate Cancer
For Colon Cancer
Our Product Pipeline
Newsroom
Press Releases
Media Resources
Social Hub
In the News
Investors
Resources
Videos
Patient Resources
Publications & Guidelines
Abstracts
Grants & Contributions
Glossary
Licenses & Accreditations
Privacy Policy
Terms & Conditions
Licenses & Accreditations
Privacy Policy
Terms & Conditions
© 2018 Genomic Health, All rights reserved.
© 2018 Genomic Health, All rights reserved.
In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, and Recurrence Score are registered trademarks, and Genomic Prostate Score, and AR-V7 Nucleus Detect are pending registered trademarks, of Genomic Health, Inc. 
© 2018 Genomic Health, All rights reserved.
In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, and Recurrence Score are registered trademarks, and Genomic Prostate Score, and AR-V7 Nucleus Detect are pending registered trademarks, of Genomic Health, Inc. 